清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection

医学 耐受性 安慰剂 不利影响 内科学 乙型肝炎表面抗原 药效学 胃肠病学 乙型肝炎病毒 药代动力学 转氨酶 乙型肝炎 队列 免疫学 病毒 病理 生物 生物化学 替代医学 酶
作者
Edward John Gane,Won Kyum Kim,Tien Huey Lim,Pisit Tangkijvanich,Jung‐Hwan Yoon,William Sievert,Wattana Sukeepaisarnjaroen,Alexander J. V. Thompson,Vedran Pavlovic,Bernadette Surujbally,Cynthia Wat,Bob D. Brown,Hardean E. Achneck,Man‐Fung Yuen
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:79 (5): 1139-1149 被引量:47
标识
DOI:10.1016/j.jhep.2023.07.026
摘要

RG6346 is an N-acetyl-D-galactosamine (GalNAc)-conjugated, double-stranded RNA interference agent targeting the HBV genome S-region. We investigated the safety, tolerability, pharmacokinetics, and pharmacodynamics of RG6346 in healthy volunteers and patients with chronic HBV infection (CHB).This first-in-human, adaptive, randomized, double-blinded, phase I study recruited three groups of participants: Group A, 30 healthy volunteers received single-dose RG6346 at 0.1, 1.5, 3.0, 6.0, or 12.0 mg/kg, or placebo; Group B, nucleos(t)ide analogue-naïve participants with CHB received single-dose RG6346 at 3.0 mg/kg (n = 6) or placebo (n = 3); Group C, participants with nucleos(t)ide-suppressed CHB received four doses (every 28 days) of RG6346 at 1.5, 3.0, or 6.0 mg/kg (n = 4 in each cohort) or placebo (n = 6).RG6346 treatment for up to 4 months was safe and well tolerated. The most common adverse event was a mild injection site reaction. Several nucleos(t)ide-naïve participants exhibited self-resolving transaminase elevations with preserved liver function. By the end of RG6346 treatment in Group C (Day 112), the mean reduction from baseline in hepatitis B surface antigen (HBsAg) was 1.39, 1.80, and 1.64 log10 IU/ml in the 1.5, 3.0, and 6.0 mg/kg cohorts, respectively. Of the 12 participants in Group C, 11 (91.7%) achieved a ≥1 log10 IU/ml reduction in HBsAg (3 of 11 [27.3%] had the response sustained at conditional follow-up Day 448). No dose-response relationship was apparent between RG6346 and serum HBsAg levels. The RG6346-induced HBsAg response was independent of hepatitis B e antigen status. Moderate-to-marked sustained reductions of hepatitis B core-related antigen, HBV RNA, HBV DNA (in nucleos[t]ide analogue-naïve participants), and hepatitis B e antigen levels were observed.These favorable safety and pharmacodynamic data support the clinical development of RG6346 as the backbone of a finite antiviral treatment regimen, with the goal of sustained HBsAg loss (functional cure) in patients with CHB.ClinicalTrials.gov NCT03772249.Currently available therapies for chronic HBV infection are associated with low rates of functional cure and new, more efficacious treatments are needed. This first-in-human study of RG6346, an RNA interference therapy, showed a favorable safety profile as well as marked and durable reductions in hepatitis B surface antigen levels. These results support the continued development of RG6346 as the backbone of a finite treatment regimen targeting high functional cure rates and are important for HBV researchers and physicians.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
3秒前
8秒前
scenery0510发布了新的文献求助10
9秒前
周立杰完成签到,获得积分10
16秒前
leapper完成签到 ,获得积分10
20秒前
JJYYY发布了新的文献求助10
21秒前
Maestro_S的应助被科研通管家采纳,获得10
22秒前
Maestro_S的应助被科研通管家采纳,获得10
22秒前
22秒前
白菜萝卜完成签到 ,获得积分10
34秒前
JJYYY完成签到,获得积分10
34秒前
尊敬的千凡完成签到,获得积分10
39秒前
KINGAZX完成签到 ,获得积分10
42秒前
huanhuan完成签到 ,获得积分10
48秒前
黑猫老师完成签到 ,获得积分10
52秒前
54秒前
lyb1853完成签到 ,获得积分10
1分钟前
失眠的热狗完成签到,获得积分10
1分钟前
1分钟前
KalEl发布了新的文献求助10
1分钟前
Nene完成签到 ,获得积分10
1分钟前
永乐完成签到 ,获得积分10
1分钟前
Gone完成签到,获得积分10
1分钟前
激动的似狮完成签到,获得积分0
1分钟前
1分钟前
1分钟前
机灵善斓完成签到,获得积分10
1分钟前
吃葡萄不吐葡萄皮的应助被HNO3采纳,获得10
1分钟前
2分钟前
syvshc完成签到,获得积分0
2分钟前
感动初蓝完成签到 ,获得积分10
2分钟前
害羞不凡完成签到,获得积分10
2分钟前
2分钟前
2分钟前
KalEl发布了新的文献求助10
2分钟前
molihuakai的应助被TingtingGZ采纳,获得10
2分钟前
呆萌尔风完成签到,获得积分10
2分钟前
2分钟前
怡然涫完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173213
求助须知:如何正确求助?哪些是违规求助? 9565567
关于积分的说明 21780511
捐赠科研通 7767373
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555730
邀请新用户注册赠送积分活动 2476697